Business Wire

CA-LIGHTBITS-LABS

9.12.2020 14:02:15 CET | Business Wire | Press release

Share
Lightbits Expand Scale Out Disaggregated Storage Capabilities for Private, Hybrid, and Edge Deployments

Lightbits Labs today announced advancements to its cloud-native storage solution, enabling customers to confidently scale their private, hybrid, and edge cloud deployments. Lightbits, recently backed by Intel Capital , has extended its solution’s capabilities with the delivery of LightOS™ 2.1. This release further enhances high-performance, scalability, and low latency. Today’s news underpins the Lightbits vision of enabling organizations to unleash hyperscale storage for private clouds, but at a fraction of the cost of even the most advanced cloud storage offerings. LightOS 2.1 further enhances QoS for logical volumes during drive failure recoveries, multi-tenancy capabilities and adds directed-availability of snapshots and thin clones.

The new age of 5G, IoT, AI and ML and ever-increasing analytic data, calls for cloud-optimized block storage volumes that support higher IOPS, higher bandwidth and sub-millisecond, low-variance I/O latency. Like the Amazon EBS io2 Block Express volumes , which was recently announced at the AWS Re:Invent conference, Lightbits Labs’ LightOS provides high-performance, low-latency block storage volumes for on-prem cloud native application environments.

“Lightbits realized early on that disaggregated, high-performance software defined storage that utilized standard Ethernet networking is what would drive successful on-premises cloud deployments,” said Avigdor Willenz, co-founder and chairman of Lightbits Labs and previously co-founder of Annapurna Labs, acquired by Amazon in 2015. “The new Amazon EBS io2 Block Express volumes utilize scalable reliable datagrams that are implemented using custom-built, dedicated hardware. We specifically developed LightOS and NVMe/TCP to avoid the need for special network hardware yet provide a level of performance similar to local NVMe.”

As AWS extends its infrastructure offerings to hybrid cloud with its Outpost offerings, it’s clear that the future of scalable infrastructure is in native cloud practices regardless of where cloud is deployed. For private, hybrid and edge cloud deployments, Lightbits’ LightOS delivers the same or better performance than the latest Amazon EBS io2 Block Express volumes at lower cost. “This enables us to bring high-performance infrastructure for all data centers with our key Intel product portfolio,” said Remi El-Ouazzane, Vice President and Data Platforms Group Chief Strategy and Business Development Officer at Intel. “Given our recent partnership with Lightbits, we’ve had strong customer momentum in the space of disaggregated storage over TCP with customers deploying the solution in production on bare metal edge, enterprise private cloud (financial), and multi-tenancy Kubernetes-based environment for cloud service providers.”

LightOS scale out disaggregated storage solution is perfect for the largest, most performance-sensitive cloud native applications with improved price-performance, ease-of-implementation, availability and scalability. Further, as AWS is now announcing with EBS Gp3 volumes, LightOS has always decoupled IOPS from storage capacity and allowed for independent scaling of storage and compute. When combining this level of performance and flexibility along with other standard features such as thin provisioning, compression, snapshots and thin clones and the ability to utilize and extend the endurance of any flash, including QLC SSDs, it delivers EBS-like “Hyperscale Storage for All” for enterprise private clouds.

Intel’s Remi El-Ouazzane further states: “Our work with Lightbits to optimize the joint solution around Intel® Xeon® Scalable Processors, Optane™ Persistent Memory, 3D NAND QLC SSDs, and Intel® Ethernet 800 Series network adapters has delivered improved performance and TCO for our customer ecosystem.”

LightOS 2.1 is available immediately and offers better performance, scalability and latency than the most advanced cloud offerings for private clouds. With a fully programmatic API, and integration with Kubernetes and OpenStack, and the choice of software-only or a fully integrated and ready-to-run appliance, Lightbits Labs’ LightOS is ready to unleash the full power of private, hybrid and edge clouds for the next 10 years of cloud architecture.

Lightbits Labs Resources

About Lightbits Labs™
Lightbits Labs “Hyperscale Storage for All” delivers composable NVMe/TCP storage that enables on-premise, hybrid cloud, and cloud native environments to independently scale storage from compute thereby unleashing hyperscale flexibility while lowering cost and performing like local flash. The highly available software-defined storage maximizes utilization, helping customers maintain operational efficiency and easily scale their business.

Founded in 2016, Lightbits pioneered NVMe/TCP and delivered the industry’s first NVMe/TCP storage solution. Lightbits is backed by strategic investors including Intel Capital, Dell Technologies Capital, Cisco Investments, and Micron, as well as top investors and VCs including Avigdor Willenz, Lip-Bu Tan, Marius Nacht, SquarePeg Capital, and WRVI Capital. Learn more at www.lightbitslabs.com or contact us at info@lightbitslabs.com .

Intel, the Intel logo, and other Intel marks are trademarks of Intel Corporation or its subsidiaries.

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte Announces FDA Approval of Jakafi XR™ (ruxolitinib) Extended-Release Tablets for the Treatment of Myelofibrosis, Polycythemia Vera and Graft-Versus-Host Disease1.5.2026 23:28:00 CEST | Press release

Jakafi XR is a once-daily, film-coated, extended-release formulation of Jakafi®(ruxolitinib)Once-daily Jakafi XR was shown to provide consistent, day-long exposure comparable to twice-daily JakafiJakafi XR will be available for pharmacy orders by May 8 Incyte (Nasdaq:INCY) today announced that the U.S. Food and Drug Administration (FDA) has approved Jakafi XR™ (ruxolitinib) extended-release tablets for the treatment of adults with intermediate- or high-risk myelofibrosis (MF); adults with polycythemia vera (PV) who have had an inadequate response to or are intolerant of hydroxyurea; as well as adults and children aged 12 years and older with steroid-refractory acute graft-versus-host disease (GVHD) or chronic GVHD after failure of one or two lines of systemic therapy. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260501334677/en/ “The approval of Jakafi XR reinforces Incyte’s leadership in hematology and our focus on meetin

Barilla Hosts Surprise Formula 1® Family Reunion Dinner During Miami Race Weekend1.5.2026 18:08:00 CEST | Press release

Drivers and team members of Formula 1® were reunited with their loved ones during a night that also celebrated the new partnership between Barilla and the Visa Cash App Racing Bulls Formula 1® Team. A special invitation, a table, and a plate of pasta shared by people who are often apart. That’s all it took for Barilla to bring the spirit of togetherness to Miami during the opening day of the FORMULA 1® CRYPTO.COM MIAMI GRAND PRIX 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260430832316/en/ Barilla hosts Arvid Lindblad, Mikaela Shiffrin, and Nico Rosberg with Chef Massimo Bottura at Torno Subito, where the Formula 1® community came together for a surprise dinner. Barilla, the Official Pasta Partner of Formula 1®, welcomed team members and their families to Torno Subito Miami, the restaurant by three-Michelin-starred Chef Massimo Bottura, with the kitchen led by Chef Bernardo Paladini, for an evening where engines wer

TIME Names Xenco Medical one of the TIME100 Most Influential Companies in the World and the Winner of the 2026 TIME100 Impact Award in Health1.5.2026 12:07:00 CEST | Press release

Time Magazine has named pioneering medical technology company Xenco Medical as one of the TIME100 Most Influential Companies in the World and the Winner of the 2026 TIME100 Impact Award in Health. Widely regarded as the most prestigious recognition in business and technology, being selected to the TIME100 List remains the most coveted accolade that a company can achieve globally. The TIME100 Impact Awards are given to only 5 recipients each year, making it the rarest of honors that a company can receive and a profound recognition of transformative, global impact. Xenco Medical was honored by Time as the sole recipient of the TIME100 Impact Award in Health in 2026, signifying its leading, global distinction in impact on healthcare. According to Time Magazine, the TIME100 Most Influential Companies list highlights “companies making an extraordinary impact around the world.” The honor bestowed by Time comes after Xenco Medical was named the 2025 Medical Device/ Diagnostics Company of the

Andersen Consulting styrker sine kompetencer inden for digital transformation med Weexa1.5.2026 10:07:00 CEST | Pressemeddelelse

Andersen Consulting indgår en samarbejdsaftale med Weexa, en global leverandør af løsninger inden for digital transformation, B2B-integration og digitalisering af forsyningskæden. Med hovedsæde i Frankrig leverer Weexa end-to-end-tjenester, der hjælper organisationer med at optimere, sikre og skalere deres digitale økosystemer. Virksomheden specialiserer sig i styring af B2B-datastrømme og digitalisering, hvilket muliggør problemfri kommunikation mellem applikationer både internt og på tværs af organisationer gennem teknologier som EDI, API'er og e-fakturering. Weexa tilbyder også SAP-integration og supply chain-løsninger til styring af lager og transport, sideløbende med strategisk rådgivning, projektlevering og vedligeholdelse af tredjepartsapplikationer. Weexa betjener organisationer inden for fødevaresektoren, detailhandel, engros, logistik, transport, bilindustrien, sundheds- og mediesektoren og hjælper globale virksomheder med at optimere deres ydeevne samt at overholde de nyeste

Inspirit Capital Completes Acquisition of Kaplan Languages Group1.5.2026 01:17:00 CEST | Press release

Inspirit Capital, a specialist investor in corporate carve-outs, and Kaplan, the global education company, have announced the completion of Inspirit’s acquisition of Kaplan Languages Group (KLG) from Kaplan. Financial terms are not being disclosed. KLG, a leading global language education platform, comprises Kaplan International Languages, Alpadia Language Schools, Azurlingua, and ESL Education. Inspirit Capital will support KLG in delivering on its ambitious growth plans, whilst continuing its fundamental mission to transform lives through language education. The next phase of ownership will see the development and launch of a refreshed standalone brand identity for KLG, with further announcements to follow on this in due course. KLG will continue to use the Kaplan name under a transitional license from Kaplan, Inc. until a new brand is announced. About Kaplan Languages Group Since 2006, KLG has provided the highest quality language education and cultural immersion experiences. Kaplan

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye